H Sawada

Summary

Affiliation: National Hospital Organization
Country: Japan

Publications

  1. doi request reprint Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease
    H Sawada
    Clinical Research Center, Utano National Hospital, Kyoto, Japan
    Eur J Neurol 16:174-82. 2009
  2. pmc Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease
    Atsushi Umemura
    Clinical Research Center, National Hospital of Utano, Kyoto, Japan
    PLoS ONE 8:e61066. 2013
  3. pmc Clinical factors associated with abnormal postures in Parkinson's disease
    Tomoko Oeda
    Clinical Research Center and Department of Neurology, National Hospital of Utano, National Hospital Organization, Kyoto City, Kyoto, Japan
    PLoS ONE 8:e73547. 2013
  4. pmc Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control study
    Hideyuki Sawada
    Clinical Research Center and Department of Neurology, National Hospital of Utano, Kyoto, Japan
    PLoS ONE 9:e85886. 2014
  5. pmc Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort study
    Hideyuki Sawada
    Clinical Research Center, 8 Ondoyamacho, Narutaki, Ukyoku Kyoto 616 8255, Japan
    BMC Neurol 13:145. 2013
  6. pmc Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trial
    Hideyuki Sawada
    Clinical Research Center, Utano National Hospital, Kyoto City, Japan
    PLoS ONE 5:e15298. 2010

Collaborators

Detail Information

Publications7

  1. doi request reprint Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease
    H Sawada
    Clinical Research Center, Utano National Hospital, Kyoto, Japan
    Eur J Neurol 16:174-82. 2009
    ..To estimate the diagnostic accuracy of cardiac (123)I-metaiodobenzylguanidine (MIBG) scintigram for detection of Parkinson disease...
  2. pmc Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease
    Atsushi Umemura
    Clinical Research Center, National Hospital of Utano, Kyoto, Japan
    PLoS ONE 8:e61066. 2013
    ..Cardiac sympathetic denervation and putaminal rarefaction are specific findings for PD and MSA-P, respectively...
  3. pmc Clinical factors associated with abnormal postures in Parkinson's disease
    Tomoko Oeda
    Clinical Research Center and Department of Neurology, National Hospital of Utano, National Hospital Organization, Kyoto City, Kyoto, Japan
    PLoS ONE 8:e73547. 2013
    ..Unlike other motor disabilities such as bradykinesia or muscular rigidity, AP is not always improved but rather deteriorated by PD medication...
  4. pmc Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control study
    Hideyuki Sawada
    Clinical Research Center and Department of Neurology, National Hospital of Utano, Kyoto, Japan
    PLoS ONE 9:e85886. 2014
    ..Though infections are associated with psychotic symptoms, whether or not subclinical inflammation is associated with hallucinations is not known in Parkinson's disease (PD)...
  5. pmc Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort study
    Hideyuki Sawada
    Clinical Research Center, 8 Ondoyamacho, Narutaki, Ukyoku Kyoto 616 8255, Japan
    BMC Neurol 13:145. 2013
    ..Therefore we aimed to investigate patient-related and medication-related risks of psychosis requiring anti-psychotic medications (serious psychosis)...
  6. pmc Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trial
    Hideyuki Sawada
    Clinical Research Center, Utano National Hospital, Kyoto City, Japan
    PLoS ONE 5:e15298. 2010
    ..The purpose of the present study was to investigate the efficacy of amantadine in Parkinson's disease patients suffering from dyskinesias...